Australia markets closed

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.0900+0.0004 (+0.45%)
At close: 04:00PM EDT
0.0900 0.00 (0.00%)
After hours: 07:03PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.15-0.09-0.270.02
Low estimate-0.25-0.14-0.41-0.02
High estimate-0.05-0.04-0.130.07
Year ago EPS-0.85-1.27-3.96-0.27
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate3.28M3.58M14.8M19.29M
Low estimate3M3M13.5M17M
High estimate3.56M4.15M16.1M21.57M
Year ago sales3.2MN/A14.73M14.8M
Sales growth (year/est)2.50%N/A0.50%30.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.91-0.55-0.4-0.3
Actual EPS-0.85-1.27-0.37-1.33
Difference0.06-0.720.03-1.03
Surprise %6.60%-130.90%7.50%-343.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.15-0.09-0.270.02
7 days ago-0.15-0.09-0.270.02
30 days ago-0.2-0.2-0.730.01
60 days ago-0.2-0.2-0.730.01
90 days ago-0.22-0.18-0.640.01
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days111N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNBYIndustrySector(s)S&P 500
Current qtr.82.40%N/AN/AN/A
Next qtr.92.90%N/AN/AN/A
Current year93.20%N/AN/AN/A
Next year107.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A